Evoke Pharma (EVOK) EBT Margin (2020 - 2025)
Historic EBT Margin for Evoke Pharma (EVOK) over the last 6 years, with Q3 2025 value amounting to 26.99%.
- Evoke Pharma's EBT Margin rose 224600.0% to 26.99% in Q3 2025 from the same period last year, while for Sep 2025 it was 36.23%, marking a year-over-year increase of 351000.0%. This contributed to the annual value of 52.22% for FY2024, which is 981900.0% up from last year.
- As of Q3 2025, Evoke Pharma's EBT Margin stood at 26.99%, which was up 224600.0% from 41.87% recorded in Q2 2025.
- In the past 5 years, Evoke Pharma's EBT Margin ranged from a high of 26.99% in Q3 2025 and a low of 2997.78% during Q1 2021
- In the last 5 years, Evoke Pharma's EBT Margin had a median value of 165.1% in 2023 and averaged 374.69%.
- As far as peak fluctuations go, Evoke Pharma's EBT Margin tumbled by 2000000000bps in 2021, and later surged by 24782400bps in 2022.
- Over the past 5 years, Evoke Pharma's EBT Margin (Quarter) stood at 463.81% in 2021, then surged by 51bps to 226.43% in 2022, then soared by 48bps to 118.58% in 2023, then soared by 70bps to 36.05% in 2024, then grew by 25bps to 26.99% in 2025.
- Its EBT Margin was 26.99% in Q3 2025, compared to 41.87% in Q2 2025 and 42.41% in Q1 2025.